SOURCE: Vycor Medical, Inc.

Vycor Medical, Inc.

August 31, 2015 08:31 ET

Vycor Medical to Present at the 4th Annual Liolios Gateway Conference on September 10, 2015

BOCA RATON, FL--(Marketwired - Aug 31, 2015) - Vycor Medical, Inc. (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, has been invited to present at the 2015 Liolios Gateway Conference being held on September 9-10, 2015 at the Four Seasons Hotel San Francisco.

Vycor CEO Peter Zachariou is scheduled to present on Thursday, September 10 at 12:00 p.m. Pacific time. He will be joined by President David Cantor for one-on-one meetings held throughout the conference.

The presentation will be webcast live at http://wsw.com/webcast/liolios/vyco and available for replay on the Gateway Conference website at www.gateway-conference.com/presenters.

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email gateway@liolios.com.

About the Gateway Conference
The 4th Annual Gateway Conference is an invite-only conference presented by Liolios, which brings together the most compelling companies with the nation's top institutional investors and analysts. This year's event features more than 90 companies from a number of growth industries, including technology, business and financial services, consumer, digital media, clean technology and life sciences. The format has been designed to give attendees direct access to senior management via company presentations, Q&A sessions and one-on-one meetings. For more information, visit www.gateway-conference.com or www.liolios.com.

About Vycor Medical, Inc.
Vycor Medical (OTCQB: VYCO) is dedicated to providing the medical community with innovative and superior surgical and therapeutic solutions. The company has a portfolio of FDA cleared medical solutions that are changing and improving lives every day. The company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach.

Vycor Medical's ViewSite™ Surgical Access Systems (VBAS) is a suite of clear cylindrical minimally invasive disposable devices that hold the potential for speedier, safer and more economical brain surgeries and a quicker patient discharge. VBAS is designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery and add tangible value to the professional medical community. The company is ISO 13485:2003 compliant, has U.S. FDA 510(k) clearance for brain and spine surgeries and full regulatory approvals for brain in Australia, Brazil, Canada, China, Europe (EU - Class III), Korea and Japan and is seeking or has partial regulatory approvals in India, Russia, Taiwan and Vietnam. For an overview of Vycor Medical's VBAS, see VBAS Video.

NovaVision provides non-invasive, computer-based rehabilitation targeted at a substantial and largely un-addressed market of people who have lost their sight as a result of stroke, or brain injury.

NovaVision's family of therapies both restore and compensate for lost vision. NovaVision's VRT is the only medical device aimed at the restoration of vision lost as a result of neurological damage which has FDA 510(k) clearance to be marketed in the U.S. NeuroEyeCoach is a compensation therapy registered in the US as a Class I 510(k) exempt device, VRT and NeuroEyeCoach are highly complementary and provided to patients in an Internet-delivered suite, to ensure broad benefits to patients.

For the latest information on the company, including media and other coverage, and to learn more, visit www.vycormedical.com, www.vycorvbas.com or www.novavision.com

Contact Information

  • Investor Relations:
    Liolios Group, Inc.
    Ronald A. Both
    Tel 1-949-574-3860
    Email Contact